NL189800C - Therapeutisch systeem in de vorm van een aan de huid te hechten pleister. - Google Patents

Therapeutisch systeem in de vorm van een aan de huid te hechten pleister.

Info

Publication number
NL189800C
NL189800C NLAANVRAGE7710213,A NL7710213A NL189800C NL 189800 C NL189800 C NL 189800C NL 7710213 A NL7710213 A NL 7710213A NL 189800 C NL189800 C NL 189800C
Authority
NL
Netherlands
Prior art keywords
plaster
skin
closed
therapeutic system
therapeutic
Prior art date
Application number
NLAANVRAGE7710213,A
Other languages
English (en)
Dutch (nl)
Other versions
NL189800B (nl
NL7710213A (nl
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NL7710213A publication Critical patent/NL7710213A/xx
Publication of NL189800B publication Critical patent/NL189800B/xx
Application granted granted Critical
Publication of NL189800C publication Critical patent/NL189800C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/06—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/32—Layered products comprising a layer of synthetic resin comprising polyolefins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2323/00—Polyalkenes
    • B32B2323/10—Polypropylene
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2556/00—Patches, e.g. medical patches, repair patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NLAANVRAGE7710213,A 1977-07-12 1977-09-16 Therapeutisch systeem in de vorm van een aan de huid te hechten pleister. NL189800C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/815,033 US4201211A (en) 1977-07-12 1977-07-12 Therapeutic system for administering clonidine transdermally

Publications (3)

Publication Number Publication Date
NL7710213A NL7710213A (nl) 1979-01-16
NL189800B NL189800B (nl) 1993-03-01
NL189800C true NL189800C (nl) 1993-08-02

Family

ID=25216676

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7710213,A NL189800C (nl) 1977-07-12 1977-09-16 Therapeutisch systeem in de vorm van een aan de huid te hechten pleister.

Country Status (34)

Country Link
US (1) US4201211A (fr)
JP (1) JPS5420129A (fr)
AR (1) AR218037A1 (fr)
AT (1) AT362884B (fr)
AU (1) AU512328B2 (fr)
BE (1) BE862585A (fr)
BG (1) BG29866A3 (fr)
CA (1) CA1089362A (fr)
CH (1) CH646876A5 (fr)
CS (1) CS216917B2 (fr)
DD (1) DD135566A5 (fr)
DE (1) DE2755661C2 (fr)
DK (1) DK159375C (fr)
ES (2) ES245891Y (fr)
FI (1) FI772754A7 (fr)
FR (1) FR2397190A1 (fr)
GB (1) GB1577259A (fr)
GR (1) GR61591B (fr)
HU (1) HU179397B (fr)
IE (1) IE46069B1 (fr)
IL (1) IL52839A (fr)
IT (1) IT1104643B (fr)
LU (1) LU78845A1 (fr)
NL (1) NL189800C (fr)
NO (1) NO772955L (fr)
NZ (1) NZ185000A (fr)
PH (1) PH16059A (fr)
PL (1) PL113984B1 (fr)
PT (1) PT67128B (fr)
RO (1) RO75336A (fr)
SE (1) SE7709731L (fr)
SU (1) SU1005650A3 (fr)
YU (1) YU41594B (fr)
ZA (1) ZA775848B (fr)

Families Citing this family (265)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
JPS57134413A (en) * 1981-02-14 1982-08-19 Nitto Electric Ind Co Ltd Percutaneous absorbable drug and product containing the same
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
JPS57150503U (fr) * 1981-03-17 1982-09-21
US4725272A (en) * 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
JPS5984813A (ja) * 1982-11-08 1984-05-16 Sekisui Chem Co Ltd 薬剤徐放性製剤
JPS5984817A (ja) * 1982-11-08 1984-05-16 Sekisui Chem Co Ltd 薬剤徐放性製剤
JPS5984814A (ja) * 1982-11-08 1984-05-16 Sekisui Chem Co Ltd 薬剤徐放性製剤
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
US4564364A (en) * 1983-05-26 1986-01-14 Alza Corporation Active agent dispenser
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
DE3344691A1 (de) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen Wirkstoffabgasesysteme
DE3347277A1 (de) * 1983-12-28 1985-07-11 Bayer Ag, 5090 Leverkusen Wirkstoffabgabesysteme
JPS60185713A (ja) * 1984-03-05 1985-09-21 Nitto Electric Ind Co Ltd 経皮吸収性製剤及びその製法
GB2156215B (en) * 1984-03-05 1988-03-02 Nitto Electric Ind Co Percutaneous absorption type adhesive pharmaceutical preparation
DE3409079A1 (de) * 1984-03-13 1985-09-19 Bayer Ag, 5090 Leverkusen Medizinische pflaster
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4655768A (en) * 1984-07-06 1987-04-07 Avery International Corporation Bandage for sustained delivery of drugs
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4532244A (en) * 1984-09-06 1985-07-30 Innes Margaret N Method of treating migraine headaches
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
EP0186019B1 (fr) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Pansement médicamenteux
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
DE3518707A1 (de) * 1985-05-24 1986-11-27 Beiersdorf Ag, 2000 Hamburg Nitro-pflaster
JPS63502986A (ja) * 1985-12-12 1988-11-02 フレックスコン・カンパニ−・インコ−ポレ−テッド 経皮方法および接着剤
US4765974A (en) * 1985-12-24 1988-08-23 Nitto Electric Industrial Co., Ltd. Preparation for percutaneous administration
US4886545A (en) * 1986-01-31 1989-12-12 Nelson Research & Development Company Compositions comprising 1-substituted azacycloalkanes and their uses
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
ES2028074T3 (es) * 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US5227157A (en) * 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
US4917688A (en) * 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
US4830856A (en) * 1987-01-27 1989-05-16 Peppers James M Chelation product
US4879275A (en) * 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
US4920101A (en) * 1987-09-30 1990-04-24 Nelson Research & Development Co. Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
US4781924A (en) 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
JPH02149514A (ja) * 1988-04-06 1990-06-08 Nitto Denko Corp 医薬部材
NL8801445A (nl) * 1988-06-06 1990-01-02 Dow Chemical Nederland Gecoextrudeerde synthetische harsstructuren en werkwijze voor de vervaardiging ervan.
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US6559186B1 (en) 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
US5070084A (en) * 1990-02-26 1991-12-03 Campbell James N Treatment of sympathetically maintained pain
US5447947A (en) * 1990-02-26 1995-09-05 Arc 1 Compositions and methods of treatment of sympathetically maintained pain
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
US5402777A (en) * 1991-06-28 1995-04-04 Alza Corporation Methods and devices for facilitated non-invasive oxygen monitoring
IT1251469B (it) * 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
PT100973A (pt) * 1991-10-18 1994-06-30 Alza Corp Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
JP3786684B2 (ja) * 1992-05-13 2006-06-14 アルザ・コーポレーション オキシブチニンの経皮投与
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
US5451407A (en) * 1993-06-21 1995-09-19 Alza Corporation Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
EP0705097B2 (fr) * 1993-06-25 2004-01-14 Alza Corporation Incorporation d'un amide poly-n-vinylique a un systeme transdermique
EP0721349A1 (fr) * 1993-09-29 1996-07-17 Alza Corporation Renforcateur de permeation de l'oxybutine a base de monoglyceride/lactate
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
CN1078460C (zh) * 1995-03-23 2002-01-30 北京三九克莱斯瑞控释药业有限公司 程控型透皮贴剂
US5662928A (en) * 1995-04-21 1997-09-02 Ciba-Geigy Corporation Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE19527925C2 (de) * 1995-07-29 1997-07-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht
CA2182851A1 (fr) * 1995-08-15 1997-02-16 August Masaru Watanabe Methode de traitement d'un etat resultant de l'arret de la consommation abusive de drogues
US6238700B1 (en) 1995-12-01 2001-05-29 Alza Corporation Method for preventing crystal formation in a dispersion of a liquid in a matrix
DE69616370T2 (de) 1995-12-01 2002-07-11 Alza Corp., Palo Alto Verbessertes verfahren zur verhinderung der kristallbildung in einer dispersion eines flüssigen stoffes in einer matrix
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US7094422B2 (en) * 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US5869089A (en) * 1996-03-21 1999-02-09 China-America Technology Corp. (Ctc) Manufacturing method of programmable transdermal therapeutic system
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
US6512010B1 (en) 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US6660295B2 (en) 1997-09-30 2003-12-09 Alza Corporation Transdermal drug delivery device package with improved drug stability
DK1041975T3 (da) 1997-12-22 2002-11-04 Alza Corp Hastighedskontrollerende membraner til anordninger til kontrolleret indførsel af medikament
US6699497B1 (en) 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
US6348210B1 (en) 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
HUP0104728A3 (en) * 1998-12-18 2006-07-28 Alza Corp Mountain View Transparent transdermal nicotine delivery device
AU778081B2 (en) * 1999-03-25 2004-11-11 Tepha, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
WO2001015671A2 (fr) 1999-08-30 2001-03-08 Tepha, Inc. Produits polymeres jetables dans les toilettes
EP1762557B1 (fr) 2000-02-16 2011-04-06 The Brigham And Women's Hospital, Inc. Mediateurs lipidiques actives par l'aspirine
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US8329734B2 (en) * 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
DK1435945T3 (da) * 2001-06-05 2008-12-01 Ronald Aung-Din Topisk migræne terapi
WO2003053423A2 (fr) * 2001-12-18 2003-07-03 The Brigham And Women's Hospital Nouvelle methode de defense antimicrobienne de l'hote utilisant des boucliers moleculaires comportant des analogues de rra et de dha
US8481772B2 (en) 2002-04-01 2013-07-09 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US7902257B2 (en) * 2002-04-01 2011-03-08 University Of Southern California Trihydroxy polyunsaturated eicosanoid
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
AU2003258194B2 (en) * 2002-08-12 2009-11-12 The Brigham And Women's Hospital, Inc. Resolvins: biotemplates for therapeutic interventions
US7759395B2 (en) 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
WO2004078143A2 (fr) * 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Procede destine a l'identification et l'utilisation de recepteurs anti-inflammatoires pour les analogues d'acides eicosapentaenoiques
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
PT1638615E (pt) 2003-05-08 2015-02-04 Tepha Inc Fibras e tecidos médicos de polihidroxialcanoato
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
US20060200100A1 (en) * 2003-06-18 2006-09-07 Rosati Coni F Method and apparatus for supplying gas to an area
US7014630B2 (en) * 2003-06-18 2006-03-21 Oxyband Technologies, Inc. Tissue dressing having gas reservoir
US20070065463A1 (en) * 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
JP2007528853A (ja) * 2003-07-08 2007-10-18 テファ， インコーポレイテッド 徐放性薬物送達のためのポリ−４−ヒドロキシブチレートマトリックス
US20050020600A1 (en) 2003-07-23 2005-01-27 Scherer Warren J. Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
EP1663017A1 (fr) * 2003-08-22 2006-06-07 Tepha, Inc. Dispositifs de regeneration nerveuse a base de polyhydroxyalkanoate
TWI239252B (en) * 2003-12-31 2005-09-11 Ind Tech Res Inst A patch and the manufacturing method of the same
EP1755537A4 (fr) * 2004-04-14 2009-12-09 Univ Boston Procédés et compositions servant à prévenir ou à traiter des maladies parodontales
US7842007B2 (en) * 2004-04-30 2010-11-30 Clawson Burrell E Apparatus and methods for isolating human body areas for localized cooling
US7611628B1 (en) 2004-05-13 2009-11-03 University Of Kentucky Research Foundation Aligned nanotubule membranes
ES2395464T3 (es) * 2004-08-03 2013-02-12 Tepha, Inc. Suturas de polihidroxialcanoato no rizadas
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
ATE471146T1 (de) 2004-10-21 2010-07-15 Durect Corp Transdermale verabreichungssysteme
US20060177513A1 (en) * 2005-01-28 2006-08-10 Tepha, Inc. Embolization using poly-4-hydroxybutyrate particles
CN101316602B (zh) 2005-09-27 2015-06-03 组织技术公司 羊膜制品和纯化的组合物及其使用方法
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8273792B2 (en) 2005-10-03 2012-09-25 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
US8026266B2 (en) * 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US7888422B2 (en) * 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
US8636986B2 (en) * 2005-11-18 2014-01-28 The Forsyth Institute Treatment and prevention of bone loss using resolvins
ES2812250T3 (es) 2005-11-28 2021-03-16 Marinus Pharmaceuticals Inc Formulaciones de ganaxolona y procedimientos para la preparación y uso de las mismas
US20070259930A1 (en) * 2006-04-10 2007-11-08 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
US8518926B2 (en) * 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
KR20090021169A (ko) * 2006-05-16 2009-02-27 크놉 뉴로사이언시스 인코포레이티드 Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
EP2056818B1 (fr) 2006-08-11 2011-05-25 The Johns Hopkins University Compositions et méthodes de neuroprotection
PL2526933T3 (pl) 2006-09-22 2015-08-31 Pharmacyclics Llc Inhibitory kinazy tyrozynowej Brutona
WO2008066899A2 (fr) 2006-11-28 2008-06-05 Marinus Pharmaceuticals Formulations de nanoparticules et procédés de préparation et d'utilisation de celles-ci
US7943683B2 (en) * 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US8524695B2 (en) * 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
US20080152709A1 (en) * 2006-12-22 2008-06-26 Drugtech Corporation Clonidine composition and method of use
WO2008103818A1 (fr) * 2007-02-21 2008-08-28 University Of Louisville Research Foundation Compositions thérapeutiques à base de cotinine
CN101715443A (zh) 2007-03-14 2010-05-26 诺普神经科学股份有限公司 手性纯化的取代的苯并噻唑二胺的合成
US8940326B2 (en) 2007-03-19 2015-01-27 Vita Sciences Llc Transdermal patch and method for delivery of vitamin B12
JP2010529142A (ja) * 2007-06-08 2010-08-26 アドレネクス・ファーマシューティカルズ，インコーポレイテッド アドレナリン調節異常症を治療する徐放性の製剤および方法
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
JP5411141B2 (ja) 2007-09-10 2014-02-12 カルシメディカ，インク． 細胞内カルシウムを調節する化合物
US9775882B2 (en) * 2007-09-20 2017-10-03 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
EP2283160A4 (fr) * 2008-05-07 2012-01-04 Wintherix Llc Procédés pour identifier des composés qui modulent la signalisation wnt dans des cellules cancéreuses
WO2009137631A2 (fr) * 2008-05-07 2009-11-12 Wintherix Llc Procédés d'identification de composés ayant une incidence sur l'expression d'isoformes de protéines associées au cancer
EP2363116A1 (fr) * 2008-06-25 2011-09-07 US Worldmeds LLC Formulations à libération prolongée comprenant de la lofexidine pour administration par voie orale
JP2011526889A (ja) 2008-06-30 2011-10-20 アフギン ファーマ，エルエルシー 局所局部的神経作用療法
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
CA2734500A1 (fr) 2008-08-27 2010-03-11 Calcimedica Inc. Composes qui modulent le calcium intracellulaire
EP2165706A1 (fr) 2008-09-18 2010-03-24 BioAlliance Pharma Traitement de la douleur inflammatoire de la muqueuse de la cavité buccale à l'aide de supports thérapeutiques bioadhésifs de muqueuse à libération prolongée
WO2010071866A2 (fr) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Combinaison thérapeutique pour l'arthrite avec du tranilast
US9175066B2 (en) 2009-04-24 2015-11-03 Tissuetech, Inc. Compositions containing HC-HA complex and methods of use thereof
CN102802418A (zh) * 2009-06-19 2012-11-28 诺普神经科学股份有限公司 用于治疗肌萎缩性侧索硬化的组合物和方法
US7741330B1 (en) 2009-10-12 2010-06-22 Pharmacyclics, Inc. Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
EP2329849B1 (fr) 2009-11-18 2015-04-29 Galderma Research & Development Combinaison d'un agoniste du récepteur alpha-2 adrénergique et d'un agent anti-inflammatoire non stéroïdien pour traiter ou empêcher un trouble cutané inflammatoire
US8394800B2 (en) 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
JP2013518909A (ja) 2010-02-08 2013-05-23 キナゲン，インク． アロステリックキナーゼ阻害が関係する治療方法および組成物
MX339192B (es) 2010-03-24 2016-05-13 Amitech Therapeutic Solutions Inc Compuestos heterociclicos utiles para inhibicion de cinasa.
KR20150058551A (ko) 2010-03-26 2015-05-28 갈데르마 리써어치 앤드 디벨로프먼트 모세혈관 확장증의 안전하고 유효한 치료를 위한 개선된 방법 및 조성물
US8513247B2 (en) 2010-03-26 2013-08-20 Galderma Laboratories, L.P. Methods and compositions for safe and effective treatment of erythema
KR20150036825A (ko) 2010-04-13 2015-04-07 나지브 바불 1-메틸-2''-6''-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
ES2602475T3 (es) 2010-04-15 2017-02-21 Tracon Pharmaceuticals, Inc. Potenciación de la actividad anticáncer por terapia de combinación con inhibidores de la vía BER
HUE029570T2 (en) 2010-04-27 2017-03-28 Calcimedica Inc Intracellular calcium modifying compounds
EP2563759B1 (fr) 2010-04-27 2022-04-06 Calcimedica, Inc. Composés qui modulent le calcium intracellulaire
WO2011135531A2 (fr) 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. DISPOSITIFS MÉDICAUX POUR L'ADMINISTRATION D'ARNsi
EP2563455A4 (fr) 2010-04-28 2014-02-19 Kimberly Clark Co Procédé d'augmentation de la perméabilité d'une barrière épithéliale
KR20130058012A (ko) 2010-04-28 2013-06-03 킴벌리-클라크 월드와이드, 인크. 사출 성형된 마이크로니들 어레이 및 마이크로니들 어레이의 형성 방법
MX345837B (es) 2010-04-28 2017-02-16 Kimberly-Clark Worldwide Incorporated Dispositivo para la entrega de un medicamento para la artritis reumatoide.
ES2688072T3 (es) 2010-05-11 2018-10-30 Mallinckrodt Ard Ip Limited ACTH para el tratamiento de la esclerosis lateral amiotrófica
NZ772688A (en) 2010-06-03 2022-09-30 Pharmacyclics Llc The use of inhibitors of bruton’s tyrosine kinase (btk)
CN103180316A (zh) 2010-08-27 2013-06-26 钙医学公司 调节细胞内钙的化合物
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
PH12013500738A1 (en) 2010-10-21 2016-08-05 Galderma Sa Brimonidine gel compositions and methods of use
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition
US8796416B1 (en) 2010-10-25 2014-08-05 Questcor Pharmaceuticals, Inc ACTH prophylactic treatment of renal disorders
US9173855B2 (en) 2010-11-02 2015-11-03 Sekisui Medical Co., Ltd. Patch
SG10202009963PA (en) 2011-01-07 2020-11-27 Allergan Inc Melanin modification compositions and methods of use
JP6527305B2 (ja) 2011-01-10 2019-06-05 インヴィオン， インコーポレイテッド 禁煙のためのβ−アドレナリン作動性インバースアゴニストの使用
US8696637B2 (en) 2011-02-28 2014-04-15 Kimberly-Clark Worldwide Transdermal patch containing microneedles
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
EP2717888B1 (fr) 2011-06-10 2020-09-09 Tissuetech, Inc. Procédés de traitement de tissus foetaux de support
MX343262B (es) 2011-10-27 2016-10-28 Kimberly Clark Co Administración transdérmica de agentes bioactivos de alta viscosidad.
CA2795586A1 (fr) 2011-11-15 2013-05-15 Golden Biotechnology Corporation Methodes et compositions pour le traitement, la modification et la gestion de la douleur attribuable au cancer des os
WO2013072763A2 (fr) * 2011-11-16 2013-05-23 Nometics Inc. Patchs transdermiques de clonidine non sensibilisants
WO2013096816A1 (fr) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Synthèse améliorée de composés substitués par amine de 4,5,6,7-tétrahydrobenzothiazole
US20130172424A1 (en) 2011-12-30 2013-07-04 Golden Biotechnology Corporation Methods and compositions for treating diabetes
US8377946B1 (en) 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
SE1350211A1 (sv) 2012-02-23 2013-08-24 Golden Biotechnology Corp Metoder och kompositioner för behandling av cancermetastaser
CN104220083B (zh) 2012-03-26 2018-11-27 国鼎生物科技股份有限公司 用于治疗动脉硬化性血管疾病的方法和组合物
ES2846789T3 (es) 2012-07-11 2021-07-29 Tissuetech Inc Composiciones que contienen complejos HC-HA/PTX3 y métodos de uso de los mismos
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
US9512116B2 (en) 2012-10-12 2016-12-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
MX2015006337A (es) 2012-11-21 2015-09-07 Golden Biotechnology Corp Metodos y composiciones para tratar enfermedades neurodegenerativas.
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
ES2927844T3 (es) 2013-01-11 2022-11-11 Corsair Pharma Inc Profármacos de treprostinil
TWI597061B (zh) 2013-02-20 2017-09-01 國鼎生物科技股份有限公司 治療白血病之方法及組成物
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
EP2968475A2 (fr) 2013-03-14 2016-01-20 Questcor Pharmaceuticals, Inc. Acth dans le traitement du syndrome de détresse respiratoire aiguë
WO2014188329A2 (fr) 2013-05-20 2014-11-27 Mylan, Inc. Système thérapeutique transdermique pour dosage à libération prolongée de pramipexole dans le traitement de troubles neurologiques
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES3043076T3 (en) 2013-07-12 2025-11-24 Areteia Therapeutics Inc Treating elevated levels of eosinophils and/or basophils
ES2871556T3 (es) 2013-08-13 2021-10-29 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de la urticaria crónica
WO2015023786A1 (fr) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions et méthodes de traitement de troubles des cellules plasmatiques et de troubles prolymphocytaires à cellules b
WO2015054283A1 (fr) 2013-10-08 2015-04-16 Calcimedica, Inc. Composés qui modulent le calcium intracellulaire
EP3077388A1 (fr) 2013-12-05 2016-10-12 Pharmacyclics, LLC Inhibiteurs de la tyrosine kinase de bruton
CN106535889A (zh) 2014-02-10 2017-03-22 帕塔拉制药有限责任公司 用于治疗肺疾病的肥大细胞稳定剂
CA2938994A1 (fr) 2014-02-10 2015-08-13 Patara Pharma, LLC Formulations inhalables de cromolyne de sodium a biodisponibilite amelioree
WO2015164213A1 (fr) 2014-04-23 2015-10-29 The Research Foundation For The State University Of New York Réaction de ligature bio-orthogonale rapide et efficace et hétérocycles contenant du bore utiles en association avec celle-ci
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
JP6561109B2 (ja) 2014-07-16 2019-08-14 コルセア ファーマ インコーポレイテッド トレプロスチニル誘導体化合物およびその使用方法
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US9839644B2 (en) 2014-09-09 2017-12-12 ARKAY Therapeutics, LLC Formulations and methods for treatment of metabolic syndrome
US10485893B2 (en) 2014-11-13 2019-11-26 Sarasota Medical Products, Inc. Antimicrobial hydrocolloid dressing containing sequestered peroxide and preparation thereof
US9359316B1 (en) 2014-11-25 2016-06-07 Concentric Analgesics, Inc. Prodrugs of phenolic TRPV1 agonists
EP3230500B1 (fr) 2014-12-11 2025-06-18 Tepha, Inc. Méthodes d'orientation de fil multifilament et de monofilaments de poly-4-hydroxybutyrate et ses copolymères
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
US10227333B2 (en) 2015-02-11 2019-03-12 Curtana Pharmaceuticals, Inc. Inhibition of OLIG2 activity
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
KR102629269B1 (ko) 2015-02-27 2024-01-24 커타나 파마슈티칼스, 인크. Olig2 활성의 억제
HK1244715A1 (zh) 2015-03-02 2018-08-17 阿福金制药有限责任公司 用大麻素的局部区域神经影响性疗法
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
TWI720984B (zh) 2015-05-20 2021-03-11 美商帝聖工業公司 用於防止上皮細胞增生及上皮-間質轉移之組合物及方法
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
EP3331522A1 (fr) 2015-08-07 2018-06-13 Patara Pharma LLC Méthodes de traitement de troubles liés aux mastocytes par des stabilisateurs de mastocytes
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
MX2018002554A (es) 2015-08-31 2018-08-14 Pharmacyclics Llc Combinaciones de inhibidores de btk para tratar mieloma multiple.
CN115006537A (zh) 2016-01-26 2022-09-06 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
WO2017147146A1 (fr) 2016-02-23 2017-08-31 Concentric Analgesics, Inc. Promédicaments d'agonistes du trpv1 phénolique
US11883381B2 (en) 2016-05-12 2024-01-30 The Regents Of The University Of Michigan ASH1L inhibitors and methods of treatment therewith
US10821105B2 (en) 2016-05-25 2020-11-03 Concentric Analgesics, Inc. Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
WO2017205766A1 (fr) 2016-05-27 2017-11-30 Pharmacyclics Llc Inhibiteurs de la kinase associée au récepteur de l'interleukine-1
WO2017205762A1 (fr) 2016-05-27 2017-11-30 Pharmacyclics Llc Inhibiteurs de la kinase associée au récepteur de l'interleukine 1
WO2017205769A1 (fr) 2016-05-27 2017-11-30 Pharmacyclics Llc Inhibiteurs de la kinase associée au récepteur de l'interleukine 1
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
KR102605329B1 (ko) 2016-08-26 2023-11-22 커타나 파마슈티칼스, 인크. Olig2 활성의 억제
EP3506893A4 (fr) 2016-08-31 2020-01-22 Respivant Sciences GmbH Compositions de cromolyne pour le traitement de la toux chronique due à une fibrose pulmonaire idiopathique
AU2017339366A1 (en) 2016-10-07 2019-04-11 Respivant Sciences Gmbh Cromolyn compositions for treatment of pulmonary fibrosis
EP3548010A1 (fr) 2016-12-05 2019-10-09 Corsair Pharma, Inc. Administration par voie cutanée et transcutanée de tréprostinil et de sels de tréprostinil
WO2019094772A1 (fr) 2017-11-10 2019-05-16 The Regents Of The University Of Michigan Agents de dégradation de ash1l et méthodes de traitement au moyen de ceux-ci
JP7414282B2 (ja) 2017-12-07 2024-01-16 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Ｎｓｄファミリー阻害物質及びそれによる治療の方法
US11685722B2 (en) 2018-02-28 2023-06-27 Curtana Pharmaceuticals, Inc. Inhibition of Olig2 activity
EP4155293B1 (fr) 2018-06-07 2025-07-30 The Regents of The University of Michigan Inhibiteurs de prc1 et méthodes de traitement comprenant ces derniers
CA3107433A1 (fr) 2018-07-27 2020-01-30 Concentric Analgesics, Inc. Promedicaments pegyles d'agonistes du trpv1 phenolique
JP7536767B2 (ja) 2018-12-31 2024-08-20 バイオメア フュージョン，インコーポレイテッド メニン－ｍｌｌ相互作用の不可逆的阻害剤
AU2020240015B2 (en) 2019-03-15 2025-10-09 Unicycive Therapeutics Inc. Nicorandil derivatives
CN111035627A (zh) * 2020-01-09 2020-04-21 范小玲 一种可乐定透皮贴及其制备方法
JP7781425B2 (ja) 2020-05-08 2025-12-08 ゴールデン バイオテクノロジー コーポレーション Ｒｎａウイルス性疾患を処置するための方法および組成物
EP4178571A4 (fr) 2020-07-10 2024-07-17 The Regents Of The University Of Michigan Inhibiteurs de gas41 et leurs méthodes d'utilisation
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition
JP7138685B2 (ja) * 2020-10-26 2022-09-16 コルセア ファーマ インコーポレイテッド トレプロスチニル誘導体化合物およびその使用方法
WO2022133064A1 (fr) 2020-12-16 2022-06-23 Biomea Fusion, Inc. Composés de pyrimidine fusionnée utilisés comme inhibiteurs de l'interaction ménine-mll
CA3228627A1 (fr) 2021-08-11 2023-02-16 Thomas Butler Inhibiteurs covalents de l'interaction menine-mll pour le diabete sucre
WO2023027966A1 (fr) 2021-08-24 2023-03-02 Biomea Fusion, Inc. Composés de pyrazine en tant qu'inhibiteurs irréversibles de flt3
US20240409558A1 (en) 2021-09-13 2024-12-12 Biomea Fusion, Inc. Irreversible inhibitors of kras
WO2023086341A1 (fr) 2021-11-09 2023-05-19 Biomea Fusion, Inc. Inhibiteurs de kras
WO2023119230A1 (fr) 2021-12-22 2023-06-29 L'oreal Compositions de modulation de la voie de coagulation et de la voie de nicotinamide-adénine dinucléotide et leurs procédés d'utilisation
CA3242316A1 (fr) 2021-12-30 2023-07-06 Biomea Fusion, Inc. Composes pyrazines utilises comme inhibiteurs de flt3
GB2618810A (en) 2022-05-17 2023-11-22 Novumgen Ltd Pharmaceutical composition for sublingual administration of clonidine
US20250353854A1 (en) 2022-06-03 2025-11-20 Biomea Fusion, Inc. Fused pyrimidine compounds as inhibitors of menin
US20250002458A1 (en) 2023-05-24 2025-01-02 Unicycive Therapeutics Inc. Salt forms of nicorandil derivative
WO2024249950A1 (fr) 2023-06-02 2024-12-05 Biomea Fusion, Inc. Composés de pyrimidine fusionnés utilisés en tant qu'inhibiteurs de la ménine
WO2025072556A1 (fr) 2023-09-26 2025-04-03 Unicycive Therapeutics, Inc. Promédicaments de nicorandil contenant des acides aminés
WO2025101867A1 (fr) 2023-11-10 2025-05-15 Albert Einstein College Of Medicine Inhibiteurs d'akt imperméables aux cellules et inhibiteurs de pdpk1
WO2025194102A1 (fr) 2024-03-15 2025-09-18 Unicycive Therapeutics, Inc. Dérivés de nicorandil modifiés par de la pyridine
WO2025208111A1 (fr) 2024-03-29 2025-10-02 Biomea Fusion, Inc. Agonistes hétérocycliques de glp-1r

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202660A (en) * 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
US3236857A (en) * 1961-10-09 1966-02-22 Boehringer Sohn Ingelheim 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
DE1928798C3 (de) * 1969-06-06 1981-06-11 C.H. Boehringer Sohn, 6507 Ingelheim Verwendung von 2-(2,6-Dichlorphenylamino)-1,3-diazacyclopenten-(2)
US3731683A (en) * 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
AR207805A1 (es) * 1975-02-06 1976-10-29 Alza Corp Substrato apropiado para formar apositos para la dispensacion continua de escopolamina base por via transdermica
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea

Also Published As

Publication number Publication date
IE46069L (en) 1979-01-12
FR2397190A1 (fr) 1979-02-09
PT67128A (fr) 1977-11-01
IL52839A0 (en) 1977-10-31
DE2755661A1 (de) 1979-01-25
PH16059A (en) 1983-06-09
US4201211A (en) 1980-05-06
DD135566A5 (de) 1979-05-16
DE2755661C2 (de) 1986-05-22
IT1104643B (it) 1985-10-21
SU1005650A3 (ru) 1983-03-15
NL189800B (nl) 1993-03-01
FR2397190B1 (fr) 1982-10-15
PL113984B1 (en) 1981-01-31
AU2846277A (en) 1979-03-08
GB1577259A (en) 1980-10-22
ES245891Y (es) 1980-12-16
CA1089362A (fr) 1980-11-11
NO772955L (no) 1979-01-15
SE7709731L (sv) 1979-01-13
JPS6214526B2 (fr) 1987-04-02
ES245891U (es) 1980-06-01
AT362884B (de) 1981-06-25
DK159375C (da) 1991-03-18
CH646876A5 (de) 1984-12-28
LU78845A1 (fr) 1979-09-06
AU512328B2 (en) 1980-10-02
RO75336A (fr) 1980-12-30
CS216917B2 (en) 1982-12-31
ATA905877A (de) 1980-11-15
IE46069B1 (en) 1983-02-09
IL52839A (en) 1979-09-30
AR218037A1 (es) 1980-05-15
DK159375B (da) 1990-10-08
DK387777A (da) 1979-01-13
JPS5420129A (en) 1979-02-15
ZA775848B (en) 1978-08-30
NZ185000A (en) 1979-08-31
NL7710213A (nl) 1979-01-16
FI772754A7 (fi) 1979-01-13
BE862585A (fr) 1978-05-02
PL204853A1 (pl) 1979-09-10
BG29866A3 (bg) 1981-02-16
ES472073A1 (es) 1979-03-16
HU179397B (en) 1982-10-28
PT67128B (fr) 1979-03-16
YU166578A (en) 1985-03-20
YU41594B (en) 1987-10-31
GR61591B (en) 1978-12-02

Similar Documents

Publication Publication Date Title
NL189800B (nl) Therapeutisch systeem in de vorm van een aan de huid te hechten pleister.
BE862722A (fr) Ustensile medical
MX145538A (es) Pieza de tuberia de enchupe de plastico y metodo para fabricar la misma
PL212042A1 (pl) Kompozycja fotopolimeryzujaca
NL175814C (nl) Werkwijze voor de bereiding van een radiologisch preparaat en voor de bereiding van een daarin te gebruiken trijoodisoftaalamide.
SE7809984L (sv) Korvskinn
ES238776Y (es) Accesorios para cursores de cierre de cremallera.
DD138877A5 (de) Pflanzenbehandlungsmittel
IT1107902B (it) Vasca da bagno perfezionata
SE7809373L (sv) Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat
NZ186787A (en) Imparting water resistance to vermiculite products
BE871884A (fr) Werkwijze voor het vervaardigen van een met een metaalfolie bekleed mineraal vezelprodukt
NL7806457A (nl) Tricycloderivaten van norbornaan en de bereiding en toepassing daarvan.
SE7808344L (sv) Elektromekanisk omvandlare
NL7806334A (nl) Omzetting van een stereoisomeer in het diastereoisomeer daarvan.
IT1105735B (it) Agente antitumorale
ES245361Y (es) Encimera perfeccionada
MX5649E (es) Procedimiento microbiologico para producir el polisacarido m-30-c
DK126878A (da) Aminfluorphosphater i tandplejemidler
MX5351E (es) Procedimiento para preparar 4-alquiltio-2-trifluorometilalcansulfonanilidas
IT1096320B (it) Prodotti superassorbenti
IT1108670B (it) Fonografo giocattolo perfezionato
FI65848B (fi) Hydraulisk stoeddaempare
DD136052A5 (de) Spreizbares befestigungsmittel
SE7808901L (sv) Forankringsbult

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 970916